Cargando…
Structural Analysis of the Simultaneous Activation and Inhibition of γ-Secretase Activity in the Development of Drugs for Alzheimer’s Disease
Significance: The majority of the drugs which target membrane-embedded protease γ-secretase show an unusual biphasic activation–inhibition dose-response in cells, model animals, and humans. Semagacestat and avagacestat are two biphasic drugs that can facilitate cognitive decline in patients with Alz...
Autores principales: | Svedružić, Željko M., Vrbnjak, Katarina, Martinović, Manuel, Miletić, Vedran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068388/ https://www.ncbi.nlm.nih.gov/pubmed/33917979 http://dx.doi.org/10.3390/pharmaceutics13040514 |
Ejemplares similares
-
Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease
por: Svedružić, Željko M., et al.
Publicado: (2013) -
Correction: Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease
por: Svedružić, Željko M., et al.
Publicado: (2013) -
Modulation of γ-Secretase Activity by Multiple Enzyme-Substrate Interactions: Implications in Pathogenesis of Alzheimer's Disease
por: Svedružić, Željko M., et al.
Publicado: (2012) -
The Binding of Different Substrate Molecules at the Docking Site and the Active Site of γ-Secretase Can Trigger Toxic Events in Sporadic and Familial Alzheimer’s Disease
por: Svedružić, Željko M., et al.
Publicado: (2023) -
In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1
por: Miletić, Vedran, et al.
Publicado: (2017)